Scythian Biosciences Inc. announced that it will receive CAD 42,500.0237 in funding on August 1, 2014. The company will issue common stock in the transaction. The company will issue securities pursuant to exemption under Regulation D. The conversion was made through the Bank of Canada noon rate of exchange as on August 1, 2014.

On January 22, 2016, Scythian Biosciences Inc. closed the transaction. The transaction included participation from six investors.